太龙药业
(600222)
| 流通市值：32.42亿 | | | 总市值：32.42亿 |
| 流通股本：5.74亿 | | | 总股本：5.74亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 369,457,742.18 | 325,392,670.76 | 284,936,283.83 | 196,666,015.69 |
| 应收票据及应收账款 | 854,921,735.69 | 841,189,937.47 | 919,460,378.05 | 882,806,520.78 |
| 其中：应收票据 | 31,131,798.15 | 27,020,143.36 | 131,838,952.54 | 143,169,278.98 |
| 应收账款 | 823,789,937.54 | 814,169,794.11 | 787,621,425.51 | 739,637,241.8 |
| 预付款项 | 98,097,315.78 | 96,819,828.9 | 94,853,471.96 | 75,306,846.45 |
| 其他应收款合计 | 51,712,520.82 | 44,687,618.18 | 69,037,130.41 | 40,231,703.53 |
| 应收股利 | - | 1,056,105.72 | - | - |
| 存货 | 519,478,814.03 | 496,011,502.94 | 459,316,852.18 | 455,499,605.26 |
| 合同资产 | 202,059,546.44 | 189,152,931.11 | 195,935,138.74 | 172,910,820.17 |
| 其他流动资产 | 26,178,369.85 | 21,820,762.81 | 18,938,208.47 | 16,352,517.16 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,150,200,044.79 | 2,039,271,552.17 | 2,070,381,963.64 | 1,993,073,631.39 |
| 非流动资产: | | | | |
| 长期股权投资 | 202,027,700.57 | 165,292,830.23 | 158,253,952.5 | 140,632,574.31 |
| 其他权益工具投资 | 307,668,863.47 | 326,442,509.36 | 339,598,025.26 | 348,276,852.24 |
| 其他非流动金融资产 | 35,454,208.19 | 35,281,469.42 | 31,690,941.66 | 31,473,641.66 |
| 投资性房地产 | 2,537,136.52 | 2,564,477.98 | 2,591,819.44 | 2,619,160.9 |
| 固定资产 | 441,080,760.02 | 449,258,058.78 | 459,007,308.84 | 469,318,933.87 |
| 在建工程 | 30,354,086.99 | 29,180,242.74 | 28,898,826.81 | 28,898,826.81 |
| 使用权资产 | 19,941,042.15 | 24,342,052.72 | 27,602,943.79 | 31,433,894.61 |
| 无形资产 | 52,384,376.32 | 53,800,185.18 | 51,136,743.36 | 52,502,812.41 |
| 开发支出 | 25,289,578.72 | 24,556,148.95 | 25,728,854.46 | 24,693,870.49 |
| 商誉 | 286,492,789.75 | 286,492,789.75 | 286,492,789.75 | 286,492,789.75 |
| 长期待摊费用 | 20,228,951.52 | 22,936,248.99 | 23,472,019.78 | 25,114,234.82 |
| 递延所得税资产 | 101,994,058.58 | 96,586,264.4 | 97,402,699.14 | 94,235,226.28 |
| 其他非流动资产 | 48,898,857.4 | 52,514,461.4 | 50,663,039.95 | 48,088,475.67 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,574,352,410.2 | 1,569,247,739.9 | 1,582,539,964.74 | 1,583,781,293.82 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,724,552,454.99 | 3,608,519,292.07 | 3,652,921,928.38 | 3,576,854,925.21 |
| 流动负债: | | | | |
| 短期借款 | 600,343,101.16 | 536,661,310.4 | 492,306,210.01 | 381,838,293.41 |
| 应付票据及应付账款 | 478,910,656.03 | 439,318,500.68 | 476,510,918.99 | 470,286,100.87 |
| 其中：应付票据 | 120,000,000 | 120,000,000 | 100,000,000 | 40,000,000 |
| 应付账款 | 358,910,656.03 | 319,318,500.68 | 376,510,918.99 | 430,286,100.87 |
| 合同负债 | 7,575,800.48 | 3,664,280.19 | 7,388,344.76 | 11,623,980.9 |
| 应付职工薪酬 | 8,633,920.55 | 10,936,427.54 | 9,602,156.03 | 17,416,754.89 |
| 应交税费 | 10,448,395.18 | 11,223,694.51 | 8,376,007.91 | 11,018,783.64 |
| 其他应付款合计 | 586,249,388.35 | 590,416,935.2 | 579,806,731.45 | 627,336,038.21 |
| 应付股利 | - | 9,984,054.05 | - | - |
| 一年内到期的非流动负债 | 304,697,456.31 | 308,351,679.08 | 156,829,414.45 | 125,108,328.86 |
| 其他流动负债 | 5,008,339.87 | 4,598,555.93 | 4,740,892.56 | 5,520,050.94 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,001,867,057.93 | 1,905,171,383.53 | 1,735,560,676.16 | 1,650,148,331.72 |
| 非流动负债: | | | | |
| 长期借款 | 6,800,000 | 6,800,000 | 165,800,000 | 183,800,000 |
| 租赁负债 | 8,615,915.82 | 11,623,263.56 | 18,840,389.77 | 19,285,549.71 |
| 长期应付款 | 60,000,000 | 60,000,000 | 70,000,000 | 70,000,000 |
| 预计负债 | - | - | 1,615,000 | 1,615,000 |
| 递延收益 | 2,868,400.11 | 3,080,483.4 | 3,169,833.39 | 3,259,183.38 |
| 递延所得税负债 | 24,464,030.65 | 21,879,746.86 | 24,016,716.38 | 25,358,343.38 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 102,748,346.58 | 103,383,493.82 | 283,441,939.54 | 303,318,076.47 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,104,615,404.51 | 2,008,554,877.35 | 2,019,002,615.7 | 1,953,466,408.19 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 573,886,283 | 573,886,283 | 573,886,283 | 573,886,283 |
| 资本公积 | 675,173,764.23 | 675,173,764.23 | 675,173,764.23 | 675,173,764.23 |
| 减:库存股 | 101,007,547.61 | 101,007,547.61 | 84,684,003.38 | 79,724,005.75 |
| 其他综合收益 | 122,365,777.18 | 106,311,023.07 | 119,466,538.97 | 128,145,365.95 |
| 盈余公积 | 50,907,095.6 | 50,907,095.6 | 50,907,095.6 | 50,907,095.6 |
| 未分配利润 | 249,016,879.51 | 246,739,018.95 | 251,363,714.91 | 230,105,075.57 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,570,342,251.91 | 1,552,009,637.24 | 1,586,113,393.33 | 1,578,493,578.6 |
| 少数股东权益 | 49,594,798.57 | 47,954,777.48 | 47,805,919.35 | 44,894,938.42 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,619,937,050.48 | 1,599,964,414.72 | 1,633,919,312.68 | 1,623,388,517.02 |
| 负债和股东权益合计 | 3,724,552,454.99 | 3,608,519,292.07 | 3,652,921,928.38 | 3,576,854,925.21 |
| 公告日期 | 2024-10-25 | 2024-08-22 | 2024-04-26 | 2024-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |